Patents by Inventor Liliana Ester Balanian

Liliana Ester Balanian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic method of treatment for inhibiting tumor development using Tamm-Horsfall glycoprotein (THP) as immunostimulating drug and compositions
    Patent number: 11730791
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting tumor development, which comprises Tamm-Horsfall glycoprotein, native or pegylated and a pharmacologically acceptable excipient, therapeutic methods and uses.
    Type: Grant
    Filed: October 12, 2021
    Date of Patent: August 22, 2023
    Assignees: INSTITUTO MASSONE S.A., Raäl Enrique Massone
    Inventors: Miguel Angel Castellano, José F. Groisman, Liliana Ester Balanian, Felipe Inserra, Emilio Sojo, Claudio Fernando Wolfenson Band, Elena M. V. de Cavanagh
  • THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS
    Publication number: 20220031805
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting tumor development, which comprises Tamm-Horsfall glycoprotein, native or pegylated and a pharmacologically acceptable excipient, therapeutic methods and uses.
    Type: Application
    Filed: October 12, 2021
    Publication date: February 3, 2022
    Inventors: Miguel Angel CASTELLANO, José F. GROISMAN, Liliana Ester BALANIAN, Felipe INSERRA, Emilio SOJO, Claudio Fernando WOLFENSON BAND, Elena M. V. de CAVANAGH
  • Therapeutic method of treatment for inhibiting tumor development using Tamm-Horsfall glycoprotein (THP) as immunostimulating drug and compositions
    Patent number: 11167009
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting tumor development, which comprises Tamm-Horsfall glycoprotein, native or pegylated and a pharmacologically acceptable excipient, therapeutic methods and uses.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: November 9, 2021
    Assignees: INSTITUTO MASSONE S.A.
    Inventors: Miguel Angel Castellano, José F. Groisman, Liliana Ester Balanian, Felipe Inserra, Emilio Sojo, Claudio Fernando Wolfenson Band, Elena M. V. de Cavanagh
  • THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS
    Publication number: 20160310568
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting tumor development, which comprises Tamm-Horsfall glycoprotein, native or pegylated and a pharmacologically acceptable excipient, therapeutic methods and uses.
    Type: Application
    Filed: July 7, 2016
    Publication date: October 27, 2016
    Inventors: Miguel Angel CASTELLANO, José F. GROISMAN, Liliana Ester BALANIAN, Felipe INSERRA, Emilio SOJO, Claudio Fernando WOLFENSON BAND
  • THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS
    Publication number: 20150005240
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting tumor development, which comprises Tamm-Horsfall glycoprotein, native or pegylated and a pharmacologically acceptable excipient, therapeutic methods and uses.
    Type: Application
    Filed: February 8, 2013
    Publication date: January 1, 2015
    Applicant: Instituto Massone S.A.
    Inventors: Miguel Angel Castellano, José F. Groisman, Liliana Ester Balanian, Felipe Inserra, Emilio Sojo, Claudio Fernando Wolfenson Band
  • Highly purified gonadotropin compositions and process for preparing them
    Patent number: 7022822
    Abstract: Purification process of humanPurification process of human urinary gonadotropins of high biological activity and chemical purity absolutely free of foreign contaminating materials derived from the use of biological reagents or chromatography dyes, from crude of gonadotropins. The high biological activity and chemically pure composition of human gonadotropins obtained by this process, are used for the treatment of infertility and are selected from the group of follitropin or menotropins, having a bioactivity greater than 2500 IU/mg protein as tested by biological assay in rats, for both FSH and LH hormones for menotropins and greater than 5000 IU/mg protein for follitropin having an FSH:LH ratio about 75:1. Pharmaceutical preparations of said gonadotropins free of these contaminating materials are also comprised within the present invention.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: April 4, 2006
    Assignee: Instituto Massone S.A.
    Inventors: Claudio Fernando Wolfenson Band, Liliana Ester Balanian, Jose-Felipe Groisman, Erundina Marta Fasanella